Peter Barrett

Insider profile

Currently holds positions in Larimar Therapeutics, Inc., Synlogic Inc, Vitae Pharmaceuticals LLC and Revvity, Inc.

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 59% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Chairman of the Board Larimar Therapeutics, Inc. Jan. 1, 2014 -
Independent Chairman of the Board Synlogic Inc Aug. 28, 2017 -
Independent Director Vitae Pharmaceuticals LLC Dec. 1, 2004 -
Independent Director Revvity, Inc. Feb. 7, 2012 -
Chairman of the Board Larimar Therapeutics, Inc. Aug. 1, 2006 - Jan. 1, 2014
Independent Director SciClone Pharmaceuticals Inc April 18, 2011 - June 27, 2013
Peter Barrett's trades of Larimar Therapeutics, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
483.82
Quantity 16,469
Value US$3,848,414
US Revvity, Inc. (RVTY)
Transaction date
Sale
Price
463.01
Quantity 7,784 -8.8%
Value US$552,010
US Revvity, Inc. (RVTY)
Transaction date
Sale
Price
308.00
Quantity 3,128 -46.9%
Value US$2,626,538
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-07-24 2023-07-24
PrS Proposed sale
16,469
483.82
US$3,848,414 		16,469 483.82 US$3,848,414
2020-05-29 2020-05-28
US Revvity, Inc. (RVTY)
S Sale
7,784 -8.8%
463.01
US$552,010 		7,784 -8.8% 463.01 US$552,010
2019-02-14 2019-02-13
US Revvity, Inc. (RVTY)
S Sale
3,128 -46.9%
308.00
US$2,626,538 		3,128 -46.9% 308.00 US$2,626,538